NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-042-2018-0-US-07 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING RSV G AND ITS USE US National Stage 16/616,873 11273214 Issued PDF
NIDCR E-152-2017-0-IL-04 FORMATION OF STABLE CARTILAGE IL National Stage 1991-08-27 Issued
NIDCR E-152-2017-0-US-05 FORMATION OF STABLE CARTILAGE US National Stage 16/616,418 10940241 Issued PDF
NHLBI E-155-2016-0-US-03 LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES US CON 16/692,849 Abandoned
NCI E-151-2019-0-US-01 Optimization Of Lead Small Molecule Inhibitors Of Taspase1 For Cancer Therapeutics US 62/939,258 Abandoned
NLM E-107-2010-2-US-31 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/691,255 Abandoned
NLM E-107-2010-2-US-30 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/691,247 Abandoned
NEI E-015-2019-0-AU-02 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE AU National Stage 2019385332 Issued
NEI E-015-2019-0-JP-08 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE JP National Stage 2021-527104 Issued
NEI E-015-2019-0-SG-10 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE SG National Stage 11202104401R Issued
NEI E-015-2019-0-CN-04 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CN National Stage 201980076370.4 Issued
NCI E-065-2017-0-US-06 HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY US National Stage 16/614,652 11389480 Issued PDF
NEI E-015-2019-0-PCT-01 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE PCT PCT COMB PCT/US2019/062016 Expired
NCI E-257-2014-0-US-04 IMMUNOGENIC MODULATION BY ENDOCRINE DEPRIVATION THERAPY IMPROVES SENSITIVITY OF TUMOR CELLS TO IMMUNE MEDIATED LYSIS US DIV 16/686,390 Abandoned
NEI E-015-2019-0-EP-06 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE EP National Stage 19832222.4 Pending
NEI E-015-2019-0-JP-09 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE JP DIV 2024-168122 Pending
NEI E-015-2019-0-KR-09 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE KR National Stage 10-2021-7018798 Pending
NEI E-015-2019-0-CA-03 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE CA National Stage 3119041 Pending
NCI E-023-2019-0-US-01 INHIBITORS OF HISTONE DEMETHYLASES US 62/936,722 Abandoned
NCATS E-128-2019-0-US-01 SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME US 62/936,823 Abandoned
NCATS E-129-2019-0-US-01 Biofabrication Of Skin Tissues With Dermis And Epidermis In Multiwell Plate Format US 62/936,399 Abandoned
NCI E-106-2017-0-US-03 ANTI-MESOTHELIN POLYPEPTIDES AND PROTEINS (15B6) US National Stage 16/613,971 11390683 Issued PDF
NCI E-040-2012-0-US-44 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US DIV 16/684,978 10837019 Issued PDF
NCI E-040-2012-0-US-45 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US DIV 16/684,994 10829769 Issued PDF
NCI E-040-2012-0-US-43 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US DIV 16/684,962 10829768 Issued PDF
NCI E-179-2019-0-US-01 PEGYLATED RECOMBINANT IMMUNOTOXINS US 62/935,822 Abandoned
CC E-158-2017-0-US-03 SYSTEMS, METHOD AND DEVICES FOR ASSISTING OR PERFORMING GUIDING INTERVENTIONAL PROCEDURES USING INERTIAL MEASUREMENT UNITS AND MAGNETOMETER SENSORS US National Stage 16/613,591 12320646 Issued PDF
NCI E-175-2016-0-HK-13 ANTI-KRAS-G12D T CELL RECEPTORS HK CN 19132196.7 Issued
NCI E-494-2013-0-DE-32 Methods of Preparing Anti-human Papillomavirus Antigen T Cells DE EP 19209253.4 Issued
NCI E-494-2013-0-IT-33 Methods of Preparing Anti-human Papillomavirus Antigen T Cells IT EP 19209253.4 Issued
NCI E-494-2013-0-FR-31 Methods of Preparing Anti-human Papillomavirus Antigen T Cells FR EP 19209253.4 Issued
NCI E-494-2013-0-NL-34 Methods of Preparing Anti-human Papillomavirus Antigen T Cells NL EP 19209253.4 Issued
NCI E-494-2013-0-ES-35 Methods of Preparing Anti-human Papillomavirus Antigen T Cells ES EP 19209253.4 Issued
NCI E-494-2013-0-EP-10 Methods of Preparing Anti-human Papillomavirus Antigen T Cells EP DIV 19209253.4 Issued
NCI E-494-2013-0-GB-36 Methods of Preparing Anti-human Papillomavirus Antigen T Cells GB EP 19209253.4 Issued
NIAID E-120-2001-1-US-01 DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES US DIV 16/684,103 11318196 Expired PDF
NCI E-040-2012-0-US-40 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,524 10900042 Issued PDF
NCI E-040-2012-0-US-41 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,543 10876123 Issued PDF
NCI E-040-2012-0-US-38 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,477 10844387 Issued PDF
NCI E-040-2012-0-US-39 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,494 10829767 Issued PDF
NCI E-040-2012-0-US-42 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 16/683,625 10815488 Issued PDF
NCI E-040-2012-0-US-35 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,417 10815487 Issued PDF
NCI E-040-2012-0-US-37 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,453 10738313 Issued PDF
NCI E-040-2012-0-US-36 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN US CON 16/683,435 10738312 Issued PDF
NCI E-017-2017-0-US-10 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US National Stage 16/613,187 11980640 Issued PDF
NIBIB E-150-2016-1-US-06 Evans Blue Attachment Enhances Somatostatin Receptor Imaging And Radiotherapy US National Stage 16/613,196 10981866 Issued PDF
NCI E-007-2019-0-PCT-02 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER PCT PCT PCT/US2019/061251 Expired
NCI E-033-2020-0-US-01 Altering The Humoral Immune Hierarchy US 62/935,016 Abandoned
NCI E-035-2017-0-CN-07 STAT3 INHIBITOR FORMULATION CN National Stage 201880031431.0 Abandoned
NCI E-085-2013-0-EP-12 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood EP DIV 19208596.7 Pending